Table 1 Demographic and clinical data for the cohort which developed metastases within a 5-year interval after primary resection (TM+) and which did not (TM-)
Variable | TM + (n = 75) | TM- (n = 346) | p-value |
|---|---|---|---|
Age [years (SD)] | 68.7 (10.1) | 71.5 (10.2) | 0.0222 |
Sex | 0.4453 | ||
female | 35 (46.7%) | 180 (52.0%) | |
male | 40 (53.3%) | 166 (48.0%) | |
Localization | 0.7023 | ||
right | 34 (45.3%) | 168 (48.6%) | |
left | 41 (54.7%) | 178 (51.4%) | |
T-stage | < 0.0001 | ||
1 | 2 (2.7%) | 34 (9.8%) | |
2 | 4 (5.3%) | 66 (19.1%) | |
3 | 55 (73.3%) | 21 (60.1%) | |
4 | 14 (18.7%) | 35 (10.0%) | |
N-stage | < 0.0001 | ||
0 | 29 (38.7%) | 249 (72.0%) | |
1 | 24 (32.0%) | 68 (19.6%) | |
2 | 22 (29.3%) | 29 (8.4%) | |
Grading | |||
1 | 1 (1.3%) | 10 (2.9%) | 0.5098 |
2 | 55 (73.4%) | 266 (76.9%) | |
3 | 19 (25.3%) | 70 (20.2%) | |
UICC-stage | < 0.0001 | ||
1 | 5 (6.7%) | 91 (26.3%) | |
2 | 24 (32.0%) | 158 (45.7%) | |
3 | 46 (61.3%) | 97 (28.0%) |